Aspergillus: A rare primary organism in soft-tissue infections

Johnson, Melissa A.; Lyle, Glenn; Hanly, Mark; Yeh, Karen A.
February 1998
American Surgeon;Feb1998, Vol. 64 Issue 2, p122
Academic Journal
Describes the case of an old woman with bilateral lower extremity fungal soft tissue infections. Treatment taken by the woman; How her body deteriorated in the hospital; Similarities between fungal soft-tissue infections and bacterial infections; Information on how aspergillus spreads through the body.


Related Articles

  • INCOMPLETE DEVELOPMENT OF THE HALLUX NAIL. Milano, A. // European Journal of Pediatric Dermatology;Apr-Jun2013, Vol. 23 Issue 2, p119 

    The article presents a case study of a four-month-old male child with presence of lesions of the big toe who was diagnosed as fungal infection, ingrown toenail and onychodystrophy and was treated with multiple systemic and topical antibiotics.

  • Aspergillosis: From the Breeze or from the Bucket? Graybill, John R. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1545 

    Introduces two articles about invasive aspergillosis.

  • Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections. Perfect, John R.; Marr, Kieren A.; Walsh, Thomas J.; Greenberg, Richard N.; DuPont, Bertrand; de la Torre-Cisneros, Juliàn; Just-Nübling, Gudrun; Schlamm, Haran T.; Lutsar, Irja; Espinel-Ingroff, Ana; Johnson, Elizabeth // Clinical Infectious Diseases;5/1/2003, Vol. 36 Issue 9, p1122 

    Treatments for invasive fungal infections remain unsatisfactory. We evaluated the efficacy, tolerability, and safety of voriconazole as salvage treatment for 273 patients with refractory and intolerant-to-treatment fungal infections and as primary treatment for 28 patients with infections for...

  • Successful Treatment of Pulmonary Invasive Aspergillosis with Voriconazole in Patients who Failed Conventional Therapy. J. Garbino; P. Rohner; L. Kolarova; A. Ondrusova; D. Lew // Infection;Aug2003, Vol. 31 Issue 4, p241 

    Background: The incidence of fungal infections, including those due to Aspergillosis species has continued to increase in recent years. Invasive aspergillosis remains an important cause of morbidity and mortality, despite therapeutics interventions. Patients and Methods: We reported five cases...

  • Cerebral Aspergillosis Caused by Neosartorya hiratsukae, Brazil. Guarro, Josep; Kallas, Esper G.; Godoy, Patricio; Karenina, Anna; Gen é, Josepa; Stchigel, Alberto; Colombo, Arnaldo Lopes // Emerging Infectious Diseases;Sep2002, Vol. 8 Issue 9, p989 

    Examines a case report of cerebral aspergillosis caused by Neosartorya hiratsukae in Brazil. Clinical features of the disease; Diagnosis; Morphological features of isolated Aspergillus species and N. hiratsukae.

  • Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report. Hanadate, Tomoko; Wakasugi, Masahiro; Sogabe, Keizo; Kobayashi, Toshimitsu; Horita, Hisanori; Kawamura, Ikuo; Hori, Yasuhiro; Matsui, Keita; Hoshino, Yo; Sou, Masahiro // Journal of Infection & Chemotherapy (Springer Science & Business;Oct2011, Vol. 17 Issue 5, p622 

    The safety and efficacy of micafungin were evaluated in a Japanese post-marketing survey involving 1,142 patients with deep mycosis caused by Candida or Aspergillus. The overall clinical response was 83.0%, and the respective responses for patients with candidiasis or aspergillosis were 86.3 and...

  • Invasive aspergillosis involving multiple paranasal sinuses--a case report. Agarwal, S.; Kanga, A.; Sharma, V.; Sharma, D. R.; Sharma, M. L. // Indian Journal of Medical Microbiology;Jul2005, Vol. 23 Issue 3, p195 

    A case of invasive multiple paranasal sinus aspergillosis with bony involvement is reported. A young immunocompetent lady presented with bilateral nasal obstruction due to polyps. Radiologically and histopathologically a fungal cause was kept a possibility, and the diagnosis of Aspegillus...

  • Prophylactic, empirical, pre-emptive and targeted antibacterial therapy all play a role in invasive aspergillosis.  // Drugs & Therapy Perspectives;Jan2009, Vol. 25 Issue 1, p18 

    The article focuses on the management of invasive aspergillosis. Described as an acute and lethal fungal infection, invasive aspergillosis usually strikes immunocompromised adult patients. The disease affects the lungs and sinuses, and cause chronic disease, like allergic bronchopulmonary...

  • Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. Russell E. Lewis; Nathan D. Albert; Dimitrios P. Kontoyiannis // Journal of Antimicrobial Chemotherapy (JAC);May2008, Vol. 61 Issue 5, p1140 

    : Objectives The safety and concentration-dependent pharmacodynamic characteristics of the echinocandins make them ideal candidates for dosage escalation in the treatment of aspergillosis. However, paradoxical attenuation of antifungal activity with increasing doses has been reported for some...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics